- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Feds to reimburse states for Part D
The federal government will reimburse states for costs they incurred in paying drug claims that should have been covered by the Medicare Part D program. CMS also said the Bush Administration will pressure Part D plans to reimburse states for the cost of claims that the insurers should have paid. The federal government will pay states the difference between what they actually paid for the drugs and what the Rx plans allow, as well as the administrative costs of running stop-gap programs. The federal reimbursement ends on Feb. 15.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
